Hepatic Artery Infusion Pump Chemotherapy, or HAI, is an advanced treatment for tumors that have spread to the liver due to metastatic colorectal cancer or metastatic bile duct cancer. HAI is a powerful tool to shrink liver tumors and reduces the risk of tumor recurrence.

2023年2月6日 · This information describes your Intera 3000 hepatic artery infusion pump (previously called the Codman pump), including how it works, how it’s placed, how it’s refilled, and activity guidelines.

2022年11月3日 · Mayo Clinic in Minnesota has begun treating liver metastases using hepatic artery infusion pump chemotherapy. This intensified, targeted chemotherapy provides potentially curative options for patients where they did not exist before.

2021年3月26日 · Hepatic arterial infusion (HAI) pumps are surgically implanted devices that deliver chemotherapeutic agents directly to the liver, typically via retrograde access of the gastroduodenal artery (GDA) to reach the hepatic arterial circulation.

2022年9月15日 · A chemotherapy infusion pump is giving more time to people whose metastatic colorectal cancer has spread to the liver and who may have been told they are out of options. Duke Health surgical oncologists were the first to implant the hepatic artery infusion (HAI) pump after it received FDA approval.

The Intera 3000 HAI Pump contains a drug reservoir which is attached to a catheter (a long tube) that connects to the hepatic artery – the blood vessel that supplies blood to tumors in the liver. The pump is made of titanium and has smooth contours. It’s about three inches in diameter, one inch thick, and weighs five ounces.

If you're receiving a hepatic artery infusion (HAI) pump, it's important to know how to best prepare for your procedure. This includes any tests you'll need before surgery, as well as what to expect as you recover.

The Intera 3000 HAI Pump contains a drug reservoir which is attached to a catheter that connects to the hepatic artery – the blood vessel that supplies blood to tumors in the liver. The pump is surgically implanted just below the skin in the abdomen.

The hepatic artery infusion pump is designed to deliver chemotherapy directly to the liver, enhancing treatment effectiveness for liver tumors. This targeted approach allows for higher concentrations of medication to reach the tumor while minimizing exposure to the rest of the body.

Penn Medicine cancer specialists are national leaders in using hepatic artery infusion (HAI) pumps to treat metastatic colon cancer (cancer that has spread from the colon to the liver) and intrahepatic cholangiocarcinoma (cancer that develops in the cells within the bile ducts both inside and outside the liver).